On November 8, 2023, the Food and Drug Administration (FDA) announced that it will be ready to accept registration and listing information for the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) by the statutory deadline of December 29, 2023 and encourages companies to meet that deadline.
Knowledge Center
Explore our library of blogs, short videos, virtual event recordings and training topics
Pages for “drug products”
Recent Blogs
FDA Releases MoCRA Draft Guidance
On August 7, 2023, the Food and Drug Administration (FDA) released draft guidance providing recommendations and instructions pertaining to the collection and submission of information related to the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), specifically, to assist persons submitting cosmetic product facility registrations and product listings to FDA.
New Drug Application (NDA): Back to the Basics
What is a New Drug Application (NDA)?Every new drug in the United States needs to come to market through a New Drug Application with the FDA. According to the FDA, “The NDA application is the vehicle through which drug sponsors formally propose that the FDA approve a...
Reed Tech SingleSource™ for Drug Products and Schlafender Hase® TVT®, the Text Verification Tool®
Reed Tech and Schlafender Hase® are leaders in the life sciences industry, working together to help ensure that pharmaceutical companies and their products are compliant with global regulatory standards. Both companies understand and solve industry challenges with...